A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome

Oliver Groß, Markus Feldkoetter, Sabine Ponsel et al.|Kidney International|2020

Cited by 151